Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07515846 · ClinicalTrials.gov registry record · NA

Breast Cancer Screening Decision Aid

A NA study, sponsored by Yale University.

Active
Registry status
NA
Development phase
300
Enrollment target

NCT07515846: Active NA study, sponsored by Yale University.

NCT07515846 is a NA study that is active but no longer recruiting, run by Yale University. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07515846, a NA study, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

This is a randomized survey study of 2 decision aids for breast cancer screening. Decision aids are tools that present structured information to patients about a medical test or treatment. The goal of this study is to compare a video-based decision aid to a written decision aid and assess the impact on intention to screen in the future, readiness to make a decision about screening, and knowledge of screening. The study will use an online survey platform (YouGov) and will include women 75 and older who have been previously screened for breast cancer and do not have a history of breast cancer.

Primary Outcome

DCS is a 16-item scale measuring uncertainty in health choices, covering informedness, values, support, uncertainty, and effective decision-making. Total scores range from 0 (no conflict) to 100 (high conflict).

Interventions

  • BEHAVIORAL Video based decision aid
  • BEHAVIORAL Written decision aid

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2026-04-28
Est. Completion 2027-04
Phase NA
Yale University

1,492 total trials

What the registry record for NCT07515846 still lists

NCT07515846 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 2 interventions - of which Video based decision aid is the first listed.

NCT07515846 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07515846 about?

NCT07515846 is a clinical study titled "Breast Cancer Screening Decision Aid". This is a randomized survey study of 2 decision aids for breast cancer screening. Decision aids are tools that present structured information to patients about a medical test or treatment. The goal of this study is to compare a video-based decision aid to a written decision aid and assess the impact...

What is the current status of trial NCT07515846?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-04-28. Estimated completion is 2027-04.

What interventions are being tested in trial NCT07515846?

The interventions under investigation include: Video based decision aid (BEHAVIORAL), Written decision aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT07515846?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07515846's enrollment target sits among peer trials

300 330th of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07515846, the US trial registry maintained by the National Library of Medicine. NCT07515846 (mid enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.